nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Amplified Centrosomes in Breast Cancer: A Potential Indicator of Tumor Aggressiveness
|
Antonino B. DAssoro |
|
2002 |
75 |
1 |
p. 25-34 10 p. |
artikel |
2 |
Amplified Centrosomes in Breast Cancer: A Potential Indicator of Tumor Aggressiveness
|
D'Assoro, Antonino B. |
|
2002 |
75 |
1 |
p. 25-34 |
artikel |
3 |
A New Estrogen Receptor Antagonist – An Overview of Available Data
|
Jones, Stephen E. |
|
2002 |
75 |
1 |
p. 19-21 |
artikel |
4 |
Announcement
|
|
|
2002 |
75 |
1 |
p. 67 |
artikel |
5 |
Choosing between Endocrine Therapy and Chemotherapy – or is there a Role for Combination Therapy?
|
Forbes, John F. |
|
2002 |
75 |
1 |
p. 37-44 |
artikel |
6 |
Dietary Intake of Selected Fatty Acids, Cholesterol and Carotenoids and Estrogen Receptor Status in Premenopausal Breast Cancer Patients
|
Jelena Jakovljevic |
|
2002 |
75 |
1 |
p. 5-14 10 p. |
artikel |
7 |
Dietary Intake of Selected Fatty Acids, Cholesterol and Carotenoids and Estrogen Receptor Status in Premenopausal Breast Cancer Patients
|
Jakovljevic, Jelena |
|
2002 |
75 |
1 |
p. 5-14 |
artikel |
8 |
Doxycycline-Inducible Expression of SPARC/ Osteonectin/ BM40 in MDA-MB-231 Human Breast Cancer Cells Results in Growth Inhibition
|
Nirada Dhanesuan |
|
2002 |
75 |
1 |
p. 73-85 13 p. |
artikel |
9 |
Doxycycline-Inducible Expression of SPARC/ Osteonectin/ BM40 in MDA-MB-231 Human Breast Cancer Cells Results in Growth Inhibition
|
Dhanesuan, Nirada |
|
2002 |
75 |
1 |
p. 73-85 |
artikel |
10 |
Fertility Cycle Influence on Surgical Breast Cancer Cure
|
Kathleen Bove |
|
2002 |
75 |
1 |
p. 65-72 8 p. |
artikel |
11 |
Fertility Cycle Influence on Surgical Breast Cancer Cure
|
Bove, Kathleen |
|
2002 |
75 |
1 |
p. 65-72 |
artikel |
12 |
Instructions for Authors
|
|
|
2002 |
75 |
1 |
p. 91-95 5 p. |
artikel |
13 |
Instructions for Authors
|
|
|
2002 |
75 |
1 |
p. 91-95 |
artikel |
14 |
Instructions for Authors
|
|
|
2002 |
75 |
1 |
p. 69-73 |
artikel |
15 |
Issues and Challenges for Antiangiogenic Therapies
|
Miller, Kathy D. |
|
2002 |
75 |
1 |
p. 45-50 |
artikel |
16 |
Ki-67 Immunostaining Activity is Higher in Positive Axillary Lymph Nodes than in the Primary Breast Tumor
|
F. Buxant |
|
2002 |
75 |
1 |
p. 1-3 3 p. |
artikel |
17 |
Ki-67 Immunostaining Activity is Higher in Positive Axillary Lymph Nodes than in the Primary Breast Tumor
|
Buxant, F. |
|
2002 |
75 |
1 |
p. 1-3 |
artikel |
18 |
New Generation Aromatase Inhibitors – from the Advanced to the Adjuvant Setting
|
Buzdar, Aman U. |
|
2002 |
75 |
1 |
p. 13-17 |
artikel |
19 |
Overview of Luteinizing Hormone-Releasing Hormone Agonists in Early Breast Cancer – Benefits of Reversible Ovarian Ablation
|
Jonat, Walter |
|
2002 |
75 |
1 |
p. 23-26 |
artikel |
20 |
Physiotherapy After Breast Cancer Surgery: Results of a Randomised Controlled Study to Minimise Lymphoedema
|
Robyn C. Box |
|
2002 |
75 |
1 |
p. 51-64 14 p. |
artikel |
21 |
Physiotherapy After Breast Cancer Surgery: Results of a Randomised Controlled Study to Minimise Lymphoedema
|
Box, Robyn C. |
|
2002 |
75 |
1 |
p. 51-64 |
artikel |
22 |
Radiation Dose, Chemotherapy and Risk of Lung Cancer After Breast Cancer Treatment
|
Carole Rubino |
|
2002 |
75 |
1 |
p. 15-24 10 p. |
artikel |
23 |
Radiation Dose, Chemotherapy and Risk of Lung Cancer After Breast Cancer Treatment
|
Rubino, Carole |
|
2002 |
75 |
1 |
p. 15-24 |
artikel |
24 |
Sequencing of Endocrine Therapies in Breast Cancer – Integration of Recent Data
|
Carlson, Robert C. |
|
2002 |
75 |
1 |
p. 27-32 |
artikel |
25 |
Shoulder Movement After Breast Cancer Surgery: Results of a Randomised Controlled Study of Postoperative Physiotherapy
|
Robyn C. Box |
|
2002 |
75 |
1 |
p. 35-50 16 p. |
artikel |
26 |
Shoulder Movement After Breast Cancer Surgery: Results of a Randomised Controlled Study of Postoperative Physiotherapy
|
Box, Robyn C. |
|
2002 |
75 |
1 |
p. 35-50 |
artikel |
27 |
Tamoxifen – An Update on Current Data and Where it Can Now be Used
|
Wickerham, Lawrence |
|
2002 |
75 |
1 |
p. 7-12 |
artikel |
28 |
The Changing Face of Breast Cancer – Meeting the Challenges
|
|
|
2002 |
75 |
1 |
p. 57-59 |
artikel |
29 |
The Changing Face of Breast Cancer – Meeting the Challenges
|
|
|
2002 |
75 |
1 |
p. 33-35 |
artikel |
30 |
The Changing Face of Breast Cancer – Past, Presentand Future Perspectives
|
Baum, Michael |
|
2002 |
75 |
1 |
p. 1-5 |
artikel |
31 |
The Role of EGFR-Directed Therapy in the Treatment of Breast Cancer
|
Morris, Charles |
|
2002 |
75 |
1 |
p. 51-55 |
artikel |
32 |
The Status of Breast Cancer Management: Challenges and Opportunities
|
Hortobagyi, Gabriel N. |
|
2002 |
75 |
1 |
p. 61-65 |
artikel |
33 |
Why and How Post-Mastectomy Edema should be Quantified in Patients with Breast Cancer
|
Christophe Galland |
|
2002 |
75 |
1 |
p. 87-89 3 p. |
artikel |
34 |
Why and How Post-Mastectomy Edema should be Quantified in Patients with Breast Cancer
|
Galland, Christophe |
|
2002 |
75 |
1 |
p. 87-89 |
artikel |